Involved field radiotherapy following auto-transplantation for lymphoma and Hodgkin's disease
β Scribed by R. Brasacchio; L. Constine; A. Rapoport; J. Rowe; S. Eberly; A. Muhs; P. Rubin
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 269 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The incidence of secondary myelodysplastic syndromes (MDS) are rarely reported in an homogeneous patient population treated for non-Hodgkin's lymphoma (NHL). Less than 10 per cent of secondary MDS are usually observed in patients treated for Hodgkin's disease and NHL. Data on the incidence of second
## Abstract The role of involved field radiation therapy (IFβRT) after high dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for nonβHodgkin's lymphoma (NHL) has not been conclusively defined. It has been hypothesized that HDC might obviate the need of consolidative IFβRT. A